IM Cannabis Stock (NASDAQ:IMCC)

Revenue Ownership Financials Chart Transcripts

Previous Close

$2.30

52W Range

$1.13 - $8.10

50D Avg

$2.44

200D Avg

$2.88

Market Cap

$6.51M

Avg Vol (3M)

$91.55K

Beta

1.68

Div Yield

-

IMCC Company Profile

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

IL

Employees

95

IPO Date

May 20, 2020

Website

IMCC Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/Service	Dec 23
ISRAEL	$43.32M

Fiscal year ends in Dec 23 | Currency in CAD

IMCC Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	$48.80M	$54.34M	$54.30M
Operating Income	$-12.18M	$-26.41M	$-38.39M
Net Income	$-9.50M	$-24.92M	$-18.52M
EBITDA	$-9.18M	$-12.37M	$-10.64M
Basic EPS	$-0.74	$-3.47	$-31.95
Diluted EPS	$-0.74	$-3.47	$-31.95

Fiscal year ends in Dec 23 | Currency in CAD

Latest Earnings Call Transcripts

Q3 24Nov 14, 24 | 10:43 AM

Q2 24Aug 14, 24 | 1:27 PM

Q1 24May 11, 24 | 8:49 AM

Peer Comparison

Ticker	Company
BFRI	Biofrontera Inc.
PAHC	Phibro Animal Health Corporation
SUPN	Supernus Pharmaceuticals, Inc.
IXHL	Incannex Healthcare Limited